National Asset Management Inc. grew its stake in shares of CVS Health Corp (NYSE:CVS) by 114.7% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,783 shares of the pharmacy operator’s stock after acquiring an additional 19,652 shares during the period. National Asset Management Inc.’s holdings in CVS Health were worth $2,006,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Capital Investment Advisory Services LLC raised its position in shares of CVS Health by 3.8% during the first quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock valued at $277,000 after buying an additional 189 shares during the last quarter. Virginia National Bank raised its position in shares of CVS Health by 4.9% during the first quarter. Virginia National Bank now owns 4,100 shares of the pharmacy operator’s stock valued at $221,000 after buying an additional 190 shares during the last quarter. Burke & Herbert Bank & Trust Co. raised its position in shares of CVS Health by 2.8% during the first quarter. Burke & Herbert Bank & Trust Co. now owns 7,466 shares of the pharmacy operator’s stock valued at $402,000 after buying an additional 200 shares during the last quarter. Fiduciary Group LLC raised its position in shares of CVS Health by 3.2% during the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock valued at $353,000 after buying an additional 200 shares during the last quarter. Finally, First Command Financial Services Inc. raised its position in shares of CVS Health by 16.0% during the second quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock valued at $80,000 after buying an additional 202 shares during the last quarter. Institutional investors and hedge funds own 75.20% of the company’s stock.

CVS has been the topic of a number of analyst reports. Cantor Fitzgerald reissued a “buy” rating and issued a $80.00 target price on shares of CVS Health in a research note on Wednesday, May 1st. Standpoint Research raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Wednesday, June 5th. Citigroup upped their target price on shares of CVS Health from $68.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. UBS Group lowered their target price on shares of CVS Health from $74.00 to $67.00 and set a “sell” rating on the stock in a research note on Thursday, May 2nd. Finally, Evercore ISI set a $63.00 target price on shares of CVS Health and gave the company a “buy” rating in a research note on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $75.14.

CVS Health stock traded up $0.40 during midday trading on Tuesday, hitting $61.79. The company’s stock had a trading volume of 275,141 shares, compared to its average volume of 8,907,550. The company has a 50-day moving average price of $56.79 and a two-hundred day moving average price of $56.41. The company has a market cap of $78.39 billion, a price-to-earnings ratio of 8.72, a PEG ratio of 1.32 and a beta of 0.90. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64. CVS Health Corp has a 1-year low of $51.72 and a 1-year high of $82.15.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the consensus estimate of $1.70 by $0.19. The company had revenue of $63.43 billion during the quarter, compared to analysts’ expectations of $62.66 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The business’s revenue for the quarter was up 35.2% compared to the same quarter last year. During the same period in the previous year, the company earned $1.69 EPS. Sell-side analysts forecast that CVS Health Corp will post 6.96 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.24%. The ex-dividend date of this dividend was Wednesday, July 24th. CVS Health’s dividend payout ratio (DPR) is presently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: Options Trading – Understanding Strike Price

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.